NEW YORK (GenomeWeb) – Diaxonhit today announced that its affiliate InGen has renewed an exclusive deal to distribute One Lambda's transplantation diagnostic tests in France.
Financial and other details of the partnership were not disclosed.
Thermo Fisher Scientific's One Lambda develops and distributes several lines of HLA typing and antibody detection assays that use serological, molecular, ELISA, flow cytometry, and Luminex's xMap technologies. The tests are used to assess the compatibility between donor and recipient before transplantation, and to follow-up on transplanted patients by monitoring potential organ rejection.
Diaxonhit is an integrated in vitro diagnostics firm that distributes IVD products for transplantation, infectious diseases, and cancer to the French market.